News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Ridgeback Capital Investments L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 7.6% stake in Bicycle Therapeutics plc |
| 02/14/2023 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 8.8% stake in Affimed N.V. |
| 02/14/2023 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 0.2% stake in F-star Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 0.2% stake in F-star Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 8.8% stake in Affimed N.V. |
| 02/14/2023 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 7.6% stake in Bicycle Therapeutics plc |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 0% stake in Cogent Biosciences Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 6.5% stake in Affimed N.V. |
| 04/09/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 0% stake in Verastem, Inc. |
| 02/16/2021 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 2.5% stake in Sutro Biopharma, Inc. |
| 02/16/2021 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 2.3% stake in Myomo, Inc. |
| 02/16/2021 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 4.5% stake in F-star Therapeutics, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 4.2% stake in 4D Molecular Therapeutics, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/06/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 0% stake in Karyopharm Therapeutics Inc. |
| 02/14/2019 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 6.5% stake in Karyopharm Therapeutics Inc. |
| 02/14/2018 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 0% stake in Verastem, Inc. |
| 01/30/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/30/2017 |
SC 13G/A
| ONCOSEC MEDICAL Inc reports a 0% stake in Oncosec Medical Inc. |
| 02/14/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/14/2012 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 9.9% stake in Ironwood Pharmaceuticals, Inc. |
| 02/14/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/14/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/16/2010 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 0% stake in Chelsea Therapeutics International, Ltd. |
| 02/16/2010 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 0% stake in Sequenom, Inc. |
| 05/01/2009 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 9% stake in Sequenom, Inc. |
| 02/17/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/17/2009 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 9.8% stake in Chelsea Therapeutics International, Ltd. |
| 02/17/2009 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 0% stake in Avigen, Inc. |
|
|
|